Cosmetics News and Research

RSS

FDA finds inconsistent amounts of belladonna in certain homeopathic teething tablets

The U.S. Food and Drug Administration announced today that its laboratory analysis found inconsistent amounts of belladonna, a toxic substance, in certain homeopathic teething tablets, sometimes far exceeding the amount claimed on the label.

23 Aug 2019

New study reveals mechanism of ultraviolet-induced skin breakdown

The sunscreen industry has been plugging the use of various sun-protective creams for decades, ever since researchers found that certain skin cancers, including malignant melanoma, were due to sunlight-induced skin damage.

22 Aug 2019

FDA approves new drug to treat adults with community-acquired bacterial pneumonia

The U.S. Food and Drug Administration today approved Xenleta (lefamulin) to treat adults with community-acquired bacterial pneumonia.

19 Aug 2019

FDA approves first spinal tether device to treat children with idiopathic scoliosis

The U.S. Food and Drug Administration today approved the first spinal tether device intended to be used in children and adolescents to correct the most common form of scoliosis, called idiopathic scoliosis, that has not responded to conservative treatment options, such as external bracing.

18 Aug 2019

FDA approves new drug to treat patients with myelofibrosis

Today, the U.S. Food and Drug Administration approved Inrebic (fedratinib) capsules to treat adult patients with certain types of myelofibrosis.

18 Aug 2019

FDA approves novel device to treat symptoms associated with advanced heart failure

The U.S. Food and Drug Administration today approved the Barostim Neo System for the improvement of symptoms in patients with advanced heart failure who are not suited for treatment with other heart failure devices, such as cardiac resynchronization therapy.

18 Aug 2019

FDA approves new drug for specific type of highly treatment-resistant tuberculosis

The U.S. Food and Drug Administration today approved Pretomanid Tablets in combination with bedaquiline and linezolid for the treatment of a specific type of highly treatment-resistant tuberculosis of the lungs.

14 Aug 2019

Statement related to data inaccuracies with newly approved gene therapy

As a public health agency, we believe that it is critical to facilitate the development of innovative safe and effective medical products, like the cellular and gene therapy products that have shown enormous potential to treat previously untreatable diseases.

7 Aug 2019

New blinking eye-on-a-chip can be used for disease modeling and drug testing

People who spend eight or more hours a day staring at a computer screen may notice their eyes becoming tired or dry, and, if those conditions are severe enough, they may eventually develop dry eye disease.

5 Aug 2019

FDA approves first therapy for symptomatic tenosynovial giant cell tumor

Today, the U.S. Food and Drug Administration granted approval to Turalio (pexidartinib) capsules for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) associated with severe morbidity or functional limitations and not responsive to improvement with surgery.

3 Aug 2019

MIT researchers develop new material that could make it easier to remove colon polyps

More than 15 million colonoscopies are performed in the United States every year, and in at least 20 percent of those, gastroenterologists end up removing precancerous growths from the colon. Eliminating these early-stage lesions, known as polyps, is the best way to prevent colon cancer from developing.

30 Jul 2019

FDA clears existing tests with new indications to aid in the diagnosis of Lyme disease

Today, the U.S. Food and Drug Administration cleared for marketing four previously cleared tests with new indications to aid in the diagnosis of Lyme disease.

30 Jul 2019

FDA approves first nasal glucagon therapy for treatment of severe hypoglycemia

The U.S. Food and Drug Administration today approved Baqsimi nasal powder, the first glucagon therapy approved for the emergency treatment of severe hypoglycemia that can be administered without an injection.

24 Jul 2019

FDA grants approval for generic versions of Lyrica

On July 19, the U.S. Food and Drug Administration approved multiple applications for first generics of Lyrica (pregabalin) for the management of neuropathic pain associated with diabetic peripheral neuropathy, for the management of postherpetic neuralgia, as an adjunctive therapy for the treatment of partial onset seizures in patients 17 years of age and older, for the management of fibromyalgia, and for the management of neuropathic pain associated with spinal cord injury.

22 Jul 2019

FDA approves antibacterial drug to treat complicated urinary tract infections, intra-abdominal infections

The U.S. Food and Drug Administration has approved Recarbrio (imipenem, cilastatin and relebactam), an antibacterial drug product to treat adults with complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI).

17 Jul 2019

Why Mattresses Could be a Health Threat to Sleeping Children

Researchers at the Israel Institute of Technology have found that children’s mattresses may represent a health hazard as they emit some dangerous pollutants at concerning levels overnight.

11 Jul 2019

$FDA grants accelerated approval to new treatment for refractory multiple myeloma$

FDA grants accelerated approval to new treatment for refractory multiple myeloma

Today, the U.S. Food and Drug Administration granted accelerated approval to Xpovio (selinexor) tablets in combination with the corticosteroid dexamethasone for the treatment of adult patients with relapsed refractory multiple myeloma who have received at least four prior therapies and whose disease is resistant to several other forms of treatment, including at least two proteasome inhibitors, at least two immunomodulatory agents, and an anti-CD38 monoclonal antibody.

3 Jul 2019

Cosmetics News and Research

FDA finds inconsistent amounts of belladonna in certain homeopathic teething tablets

New study reveals mechanism of ultraviolet-induced skin breakdown

FDA approves new drug to treat adults with community-acquired bacterial pneumonia

FDA approves first spinal tether device to treat children with idiopathic scoliosis

FDA approves new drug to treat patients with myelofibrosis

FDA approves novel device to treat symptoms associated with advanced heart failure

FDA approves new drug for specific type of highly treatment-resistant tuberculosis

Statement related to data inaccuracies with newly approved gene therapy

New blinking eye-on-a-chip can be used for disease modeling and drug testing

FDA approves first therapy for symptomatic tenosynovial giant cell tumor

MIT researchers develop new material that could make it easier to remove colon polyps

FDA clears existing tests with new indications to aid in the diagnosis of Lyme disease

FDA approves first nasal glucagon therapy for treatment of severe hypoglycemia

FDA grants approval for generic versions of Lyrica

FDA approves antibacterial drug to treat complicated urinary tract infections, intra-abdominal infections

Why Mattresses Could be a Health Threat to Sleeping Children

FDA grants accelerated approval to new treatment for refractory multiple myeloma

FDA approves first drug for treatment of neuromyelitis optica spectrum disorder

First treatment approved by FDA for chronic rhinosinusitis with nasal polyps

FDA approves new drug to treat hypoactive sexual desire disorder in premenopausal women

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News